OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages a series of venture capital funds and a family of public equity investment funds.

OrbiMed's investment team includes over 40 experienced professionals with backgrounds in science, medicine, the life science industry, finance, and law. The firm's diverse team of professionals has a unique understanding of industry dynamics through active participation in both public and private companies. Our professionals work together in a collaborative, team-oriented approach which seamlessly integrates our public and private equity platforms. OrbiMed seeks to be the capital provider of choice for life sciences companies pursuing growth and new opportunities. Where appropriate, OrbiMed supports its portfolio companies in achieving strategic, financial and operational objectives via participation on the Board of Directors. OrbiMed professionals currently serve on the Board of Directors of dozens of different life sciences companies worldwide.